Upon pre‐treatment with Pitstop 2B, no change in the uptake of recombinant 2N4R tau aggregates (Wu et al., 2013) or AD brain‐derived tau oligomers (Puangmalai et al., 2020) was observed in primary neuronal cultures. The gene discussed is MAPT; the disease is Alzheimer disease.